These apparently contradictory data are somehow in line with the data obtained from genetically engineered mouse models, in which reduced expression of ERRγ accelerated the progression of cardiac dysfunction during embryonic development or in response to increased cardiac overload [16,17,18], whereas, as demonstrated in the present study, sustained overexpression induces severe heart failure. The gene discussed is ESRRG; the disease is heart failure.